Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?
- PMID: 26629316
- PMCID: PMC4657128
- DOI: 10.4331/wjbc.v6.i4.333
Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?
Abstract
Global alterations in epigenetic landscape are now recognized as a hallmark of cancer. Epigenetic mechanisms such as DNA methylation, histone modifications, nucleosome positioning and non-coding RNAs are proven to have strong association with cancer. In particular, covalent post-translational modifications of histone proteins are known to play an important role in chromatin remodeling and thereby in regulation of gene expression. Further, histone modifications have also been associated with different aspects of carcinogenesis and have been studied for their role in the better management of cancer patients. In this review, we will explore and discuss how histone modifications are involved in cancer diagnosis, prognosis and treatment.
Keywords: Cancer; Diagnosis; Epigenetics; Histone post-translational modifications; Prognosis; Treatment.
Figures
References
-
- Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428. - PubMed
-
- Waddington CH. The epigenotype. 1942. Int J Epidemiol. 2012;41:10–13. - PubMed
-
- Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27–56. - PubMed
-
- Castelo-Branco G, Bannister AJ. The epigenetics of cancer: from non-coding RNAs to chromatin and beyond. Brief Funct Genomics. 2013;12:161–163. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
